Kas has a strong interest in the role of mathematical methods to aid decision support in drug discovery and development. Prior to joining Applied Biomath, Kas led the Bioinformatics group at Syngene International which integrated data and created models to support programs across the drug discovery pipeline; from target identification and validation through lead optimization and clinical trial design. Prior to Syngene, he was Chief Scientific Officer at Strand Life Sciences Pvt. Ltd where he led the groups involved in the development of the Sarchitect Platform, the Virtual Liver and the interpretation platforms for NGS-based diagnostics. He headed the Collaborative R&D group for immunology products at Entelos and has also worked at Genetic Therapy Inc (Novartis) where he helped found a group to perform research in synthetic and hybrid vectors for gene delivery. In 2015, Kas was elected as a Fellow of the Indian National Academy of Engineering.
He has a B.Tech. in chemical engineering from the Indian Institute of Technology, Bombay and an MS from SUNY at Buffalo. His Ph.D. is in Biomedical Engineering from the Johns Hopkins University, School of Medicine.
- Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A therapy over monalizumab for the treatment of cancer